Clinical trial simulation
Applications across R&D
Resources
Publications & posters
White papers
Therapeutic areas
Case studies & deep dives
eBook
Webinars & tutorials
Glossary
Blog
About us
Leadership
Our clients
Careers
jinkō
simulation platform
Home
>
Resources
>
Case studies & deep dives
Case studies & deep dives
Publications & posters
Case studies & deep dives
Therapeutic areas
White papers
eBook
Webinars & tutorials
Glossary
Reset filters
Publication date: Oct 28, 2022
Atopic dermatitis
Nova has built a mechanistic model of AD representing the interplay between the skin barrier and the immune system in a pediatric population.
Learn more
Publication date: Jun 28, 2022
NASH
Non-alcoholic fatty liver disease (NAFLD) is a common disorder characterized by an accumulation of excess fat inthe liver (hepatic steatosis).
Learn more
Publication date: May 25, 2022
Respiratory tract infection
Even before the Covid-19 pandemic, RTIs were a leading cause of hospitalization in children, many of whom may go on to develop chronic conditions such as asthma.
Learn more
Publication date: Jan 20, 2022
Myocardial reperfusion injury
Applied to myocardial reperfusion injury this in silico clinical trial shows the efficacy of the inhibition of reactive oxygen species production in ST elevated myocardial infarction.
Learn more
Publication date: Dec 12, 2021
LUAD Non-Small Cell Lung Cancer (NSCLC)
Non small cell lung cancer (NSCLC) makes up the majority of lung cancer cases and there is significant unmet medical need in this indication.
Learn more
Publication date: Nov 20, 2020
Hepatitis B
Exploring a drug candidate, the nova team simulated a Phase 2 trial, exploring a number of treatment regimens on a large variety of patients and treatment combinations.
Learn more
See more